EZH2 inhibition sensitizes MYC-high medulloblastoma cancers to PARP inhibition by regulating NUPR1-mediated DNA repair. Yu J, Han J, Yu M, Rui H, et al. Oncogene 2024 Nov 19. doi: 10.1038/s41388-024-03232.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yu J, Han J, Yu M, Rui H, et al. EZH2 inhibition sensitizes MYC-high medulloblastoma cancers to PARP inhibition by regulating NUPR1-mediated DNA repair. Oncogene 2024 Nov 19. doi: 10.1038/s41388-024-03232.
PMID: 39562655